Ferumoxytol administration does not alter infarct volume or the inflammatory response to stroke in mice

Ferumoxytol is an ultrasmall superparamagnetic iron oxide (USPIO) nanoparticle that is FDA approved as an intravenous iron replacement therapy for the treatment of iron deficiency anemia in patients with chronic kidney disease. Ferumoxytol has also been used as a contrast agent for cerebral blood vo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurosci Lett
Asıl Yazarlar: Doyle, Kristian P, Quach, Lisa N, D’Arceuil, Helen E, Buckwalter, Marion S
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4268374/
https://ncbi.nlm.nih.gov/pubmed/25449870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neulet.2014.10.041
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller